The Stem Cell Podcast

Ep. 81: “Organoids and Zika” Featuring Drs. Kevin Eggan and Michael Wells

Dec 20, 2016
Dr. Kevin Eggan, Harvard professor who models neurological disease, and Dr. Michael Wells, postdoc who built iPSC-derived organoid Zika models, discuss organoids used to probe how Zika infects developing brain tissue. They cover CRISPR knockouts like AXL, redundant entry pathways, innate immune roles, and whether Zika will become endemic or be controlled. Practical lab approaches and long-term risks are debated.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

AXL Not The Sole Entry Point

  • Genetic ablation of AXL did not prevent Zika infection in human neural progenitors or cerebral organoids.
  • This implies AXL is not the sole viral entry route into those brain cells.
ANECDOTE

Personal Motivation And Collaboration

  • Michael Wells joined Kevin Eggan's lab and began Zika work in February motivated by family in El Salvador.
  • He coordinated with Novartis to generate AXL knockout lines for the study.
INSIGHT

AXL Knockout Still Permits Infection

  • Michael Wells and team found Zika infects both wild-type and AXL-mutant NPCs and organoids.
  • That result directs researchers to search beyond AXL for entry mechanisms.
Get the Snipd Podcast app to discover more snips from this episode
Get the app